Diabetes mellitus and myocardial mitochondrial dysfunction: bench to bedside.
Standard
Diabetes mellitus and myocardial mitochondrial dysfunction: bench to bedside. / König, Alexandra; Bode, Christoph; Bugger, Heiko.
in: Heart Fail Clin, Jahrgang 8, Nr. 4, 4, 2012, S. 551-561.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Diabetes mellitus and myocardial mitochondrial dysfunction: bench to bedside.
AU - König, Alexandra
AU - Bode, Christoph
AU - Bugger, Heiko
PY - 2012
Y1 - 2012
N2 - In diabetics, the risk for development of heart failure is increased even after adjusting for coronary artery disease and hypertension. Although the cause of this increased heart failure risk is multifactorial, increasing evidence suggests that dysfunction of myocardial mitochondria represents an important pathogenetic factor. To date, no specific therapy exists to treat mitochondrial function in any cardiac disease. This article presents underlying mechanisms of mitochondrial dysfunction in the diabetic heart and discusses potential therapeutic options that may attenuate these mitochondrial derangements.
AB - In diabetics, the risk for development of heart failure is increased even after adjusting for coronary artery disease and hypertension. Although the cause of this increased heart failure risk is multifactorial, increasing evidence suggests that dysfunction of myocardial mitochondria represents an important pathogenetic factor. To date, no specific therapy exists to treat mitochondrial function in any cardiac disease. This article presents underlying mechanisms of mitochondrial dysfunction in the diabetic heart and discusses potential therapeutic options that may attenuate these mitochondrial derangements.
KW - Humans
KW - Oxidative Stress
KW - Risk Assessment/methods
KW - Antioxidants/therapeutic use
KW - Myocardium/metabolism/pathology
KW - Diabetes Mellitus, Type 2/complications/drug therapy/pathology
KW - Heart Failure/drug therapy/etiology
KW - Mitochondria/metabolism/pathology
KW - Mitochondrial Diseases/complications/drug therapy/pathology
KW - Humans
KW - Oxidative Stress
KW - Risk Assessment/methods
KW - Antioxidants/therapeutic use
KW - Myocardium/metabolism/pathology
KW - Diabetes Mellitus, Type 2/complications/drug therapy/pathology
KW - Heart Failure/drug therapy/etiology
KW - Mitochondria/metabolism/pathology
KW - Mitochondrial Diseases/complications/drug therapy/pathology
M3 - SCORING: Journal article
VL - 8
SP - 551
EP - 561
JO - HEART FAIL CLIN
JF - HEART FAIL CLIN
SN - 1551-7136
IS - 4
M1 - 4
ER -